State Street
IMUC

State Street’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

State Street’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-729
Closed -$4K – 3748
2016
Q3 		$4K Hold
729
– – ﹤0.01% 3593
2016
Q2 		$7K Hold
729
– – ﹤0.01% 3713
2016
Q1 		$8K Hold
729
– – ﹤0.01% 3708
2015
Q4 		$11K Hold
729
– – ﹤0.01% 3694
2015
Q3 		$12K Hold
729
– – ﹤0.01% 3694
2015
Q2 		$14K Hold
729
– – ﹤0.01% 3694
2015
Q1 		$14K Hold
729
– – ﹤0.01% 3651
2014
Q4 		$22K Sell
729
-85
-10% -$2.45K ﹤0.01% 3643
2014
Q3 		$29K Hold
814
– – ﹤0.01% 3620
2014
Q2 		$36K Hold
814
– – ﹤0.01% 3576
2014
Q1 		$40K Hold
814
– – ﹤0.01% 3574
2013
Q4 		$30K Sell
814
-175
-18% -$16.6K ﹤0.01% 3577
2013
Q3 		$102K Sell
989
-68
-6% -$7.47K ﹤0.01% 3461
2013
Q2 		$82K Buy
+1,057
New +$101K ﹤0.01% 3392

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return